Management of advanced renal cell carcinoma
摘要
Radiotherapy and chemotherapy have little or no effect on advanced renal cell carcinoma, leading to a poor prognosis. Several factors couLd affect the survival rate of RCC. Some RCC patients could partly respond to immunotherapy.The newly emerging targeted therapy has a dramatic tuning point in improving outcomes for RCC. Further understanding of the anti-RCC mechanisms involves in chemokine-mediated angiogenesis and RCC cell proliferation. These new agents include Sorafenib, Sunitinib, Temsirolimus, Bevacizumab, etc. Combination treatment with immunotherapy may lead to improved outcomes in this disease. Key words: Kidney ; Renal cell carcinoma ; Targetedtherapy ; Prognosis ;
引用本文（GB/T 7714）
张峰波, 杨培谦, 吕文成, 等. Management of advanced renal cell carcinoma[J]. 国际外科学杂志, 2010.
引文网络
本站仅收录题录与摘要供学习参考，全文版权归属出版方；如有侵权请联系我们删除。